IMRIS Completes First Two Cases For Pediatric Horseshoe Headrest

Life Science Investing News

IMRIS Inc. (TSX:IM,NASDAQ:IMRS) completed its first two cases using MR-safe headrest designed specifically for intraoperative imaging with VISIUS® intraoperative MRI (iMRI).

IMRIS Inc. (TSX:IM,NASDAQ:IMRS) completed its first two cases using MR-safe headrest designed specifically for intraoperative imaging with VISIUS® intraoperative MRI (iMRI). The IMRIS horseshoe headrest is the world’s first MR-safe and CT-compatible horseshoe headrest on the market, used for neonatal to adult patients during neurosurgical procedures requiring intraoperative imaging in the VISIUS® Surgical Theatre.

As quoted in the press release:

“The IMRIS horseshoe headrest worked well for providing the ideal prone positioning during this procedure,” said Dr. Frederick Boop, Chairman of the Department of Neurosurgery and Co-director of Le Bonheur’s Neuroscience Institute who performed the first case of a tumor surgery on a five- year-old child. “In the past we would not have had an iMRI option for this child and now the tumor is completely gone. We have now advanced our treatment to a group of kids for whom it will really make a difference. Even our youngest and most fragile patients can benefit from intraoperative MR, which would not have been possible otherwise.”

Click here to read the IMRIS Inc. (TSX:IM) press release

The Conversation (0)
×